a PhD in Experimental Medicine, Department of Clinical-Surgical, Diagnostic and Paediatric Sciences , University of Pavia , Pavia , Italy.
b Department of Chemistry and Pharmacy , University of Sassari , Sassari , Italy.
Expert Opin Drug Deliv. 2018 May;15(5):459-467. doi: 10.1080/17425247.2018.1446937. Epub 2018 Mar 6.
Lymphatic vessels are the preferential route of most solid tumors to spread their metastases in the body. The onset of metastatic nests in draining lymph nodes (LNs) are a significant indicator of cancer progression and a dismaying sign of worsen staging. Therefore, the individuation and elimination of cancer cells within the lymphatic system (LS) are an important goal. Nevertheless, the targeting of the LS with traditional contrast agents and/or chemotherapeutics is difficult, due to its anatomical structure. For this reason, many studies on new lymphatic delivery systems have been carried out, both to improve lymphatic imaging and to selectively carry chemotherapeutics to LNs, reducing the exposure of healthy tissues to the cytotoxic substances. This is an overview of the present situation in the field of detection and treatment strategies of lymphatic metastases, taking into account the use of nano-drug delivery systems. Nanocarriers, thanks to their small size and other physicochemical characteristics, are suitable vectors for imaging and chemotherapy of the LS.
The role of the LS in tumor progression and importance of treatment and imaging strategies of lymphatic metastases.
The nanoparticles are a promising approach for treatment and detection of lymphatic metastases. However further studies are necessary in order to evaluate their efficacy in human clinical application.
淋巴管是大多数实体瘤转移其转移灶到体内的首选途径。引流淋巴结 (LN) 中转移性巢的出现是癌症进展的重要指标,也是分期恶化的令人沮丧的迹象。因此,在淋巴管系统 (LS) 中识别和消除癌细胞是一个重要目标。然而,由于其解剖结构,传统的对比剂和/或化疗药物靶向 LS 具有一定难度。出于这个原因,已经进行了许多关于新型淋巴递药系统的研究,以期改善淋巴成像并选择性地将化疗药物递送至 LN,从而减少健康组织暴露于细胞毒性物质的风险。这是对当前 LS 中淋巴转移检测和治疗策略领域的概述,同时考虑了纳米药物递药系统的应用。纳米载体由于其小尺寸和其他物理化学特性,是 LS 成像和化疗的合适载体。
LS 在肿瘤进展中的作用以及淋巴转移的治疗和成像策略的重要性。
纳米颗粒是治疗和检测淋巴转移的有前途的方法。然而,为了评估其在人类临床应用中的疗效,还需要进一步的研究。